However, in the fields other than pulmonary inflammation, anti-inflammatory properties of LPA have been proposed: LPA5 negatively modulates the immune responses by inhibiting the antigen-dependent activation of the B-cell and T-cell receptor [44–47]. The gene discussed is LPAR5; the disease is inflammatory response.